UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) off The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): October 19, 2017
GENUFOOD ENERGY ENZYMES CORP.
(Exact name of registrant as specified in charter)
Nevada | 333-171784 | 68-0681158 |
(State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
601 South Figueroa Street, Suite 4050 Los Angeles, California |
90017 |
(Address of principal executive offices) | (Zip Code) |
(213) 337-6770
Registrant’s telephone number
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a -12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d -2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e -4(c))
1 |
Item 4.01. | Changes In Registrant's Certifying Accountant. |
(b) Appointment of New Independent Registered Public Accounting Firm.
On October 19, 2017, the Board of Directors of Genufood Energy Enzymes Corp. (the “Company”) approved the engagement of DYH & Company (“DYH”) as its principal accountant to audit the Company’s financial statements. During the Company's two most recent fiscal years or subsequent interim period, the Company has not consulted with the entity of DYH regarding the application of accounting principles to a specific transaction, either completed or proposed, or the type of audit opinion that might be rendered on the Company's financial statements, nor did the entity of DYH provide advice to the Company, either written or oral, that was an important factor considered by the Company in reaching a decision as to the accounting, auditing or financial reporting issue.
Further, during the Company's two most recent fiscal years or subsequent interim period, the Company has not consulted the entity of DYH on any matter that was the subject of a disagreement or a reportable event.
2 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
GENUFOOD ENERGY ENZYMES CORP. | |||
Date: October 19, 2017 | By: | /s/ Yi Ling Chen | |
Yi Ling Chen, Director |
3 |